APA (7th ed.) Citation

S, B., C, B., A, I., D, R., AF, G., & V, R. (2019). Immune-checkpoint inhibitors and candidate surrogate endpoints for overall survival across tumour types: A systematic literature review. Critical reviews in oncology/hematology, 137, 35. https://doi.org/10.1016/j.critrevonc.2019.02.013

Chicago Style (17th ed.) Citation

S, Branchoux, Bellera C, Italiano A, Rustand D, Gaudin AF, and Rondeau V. "Immune-checkpoint Inhibitors and Candidate Surrogate Endpoints for Overall Survival Across Tumour Types: A Systematic Literature Review." Critical Reviews in Oncology/hematology 137 (2019): 35. https://doi.org/10.1016/j.critrevonc.2019.02.013.

MLA (9th ed.) Citation

S, Branchoux, et al. "Immune-checkpoint Inhibitors and Candidate Surrogate Endpoints for Overall Survival Across Tumour Types: A Systematic Literature Review." Critical Reviews in Oncology/hematology, vol. 137, 2019, p. 35, https://doi.org/10.1016/j.critrevonc.2019.02.013.